Monitor for actual sale execution; while routine, director-level sales may signal sentiment, especially in a small-cap biotech. However, this appears to be a routine exercise of vested options rather than a large-scale exit.
Price Chart
Executive Summary
Daniel Spiegelman, a director of Kyverna Therapeutics, filed a Form 144 to notify the intent to sell 17,578 shares of common stock, following a stock option exercise on April 7, 2026. The transaction is valued at approximately $162,637 based on the current market price.
Key Facts
- Reporting person: Daniel Spiegelman, Director of Kyverna Therapeutics
- Number of shares intended for sale: 17,578
- Transaction type: Stock option exercise followed by proposed sale under Rule 144
- Date of filing: April 7, 2026
- Estimated sale value: $162,637 (based on ~$9.25/share, inferred from $543M market cap and outstanding shares context)
Financial Impact
Approximately $162,637 in insider shares may be sold
Risk Factors
- Potential near-term downward pressure on stock if sale is executed in a concentrated manner
- Perception of insider disengagement, though not material given small size
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003285 |
| Document: 0001950047-26-003285-index.html | 0001950047-26-003285 |
| Document: 0001950047-26-003285.txt | 0001950047-26-003285 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | SC 13G | $5.83 $6.04 | ▲ +3.60% | ▲ +3.27% | $5.27 (−9.61%) |
Sep 24, 2026 4w ago | 8-K | $6.99 $6.81 | ▼ −2.58% | ▼ −3.12% | $5.27 (−24.61%) |
Aug 11, 2026 10w ago | 8-K | $8.05 $8.08 | ▲ +0.37% | ▼ −0.33% | $5.27 (−34.53%) |
Aug 11, 2026 10w ago | Press Release | $8.05 $8.08 | ▲ +0.37% | ▼ −0.33% | $5.27 (−34.53%) |
Jul 27, 2026 13w ago | 8-K | $7.92 $7.49 | ▼ −5.43% | ▼ −5.67% | $5.27 (−33.46%) |
Jul 9, 2026 15w ago | 8-K | $9.81 $8.49 | ▼ −13.51% | ▼ −13.94% | $5.27 (−46.28%) |
Jun 11, 2026 19w ago | Institutional Cluster | $8.06 $8.15 | ▼ −1.18% | ▲ +0.58% | $5.27 (+34.57%) |
May 4, 2026 25w ago | 8-K | $9.00 $9.21 | ▲ +2.33% | ▲ +1.54% | $5.27 (−41.44%) |
Apr 22, 2026 26w ago | 8-K | $10.23 $8.95 | ▼ −12.51% | ▼ −12.12% | $5.27 (−48.48%) |
Apr 20, 2026 27w ago | Press Release | $11.25 $9.71 | ▼ −13.69% | ▼ −13.04% | $5.27 (−53.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers